Boutique private markets advisor specializing in growth-stage and lower-middle-market equity and credit investments, Kings Path Partners LLC provides deal sourcing, capital placement and portfolio advisory for institutional and family-office clients. The firm positions itself as a sector-agnostic partner with emphasis on operational due diligence, co-investment facilitation and bespoke fund structuring to support scalable operating companies and sponsor-led transactions.
Boutique private markets advisor specializing in growth-stage and lower-middle-market equity and credit investments, Kings Path Partners LLC provides deal sourcing, capital placement and portfolio advisory for institutional and family-office clients. The firm positions itself as a sector-agnostic partner with emphasis on operational due diligence, co-investment facilitation and bespoke fund structuring to support scalable operating companies and sponsor-led transactions.
A boutique private‑markets advisor seeks to deploy patient, concentrated private‑markets capital into growth-stage and lower‑middle‑market companies via direct equity, credit and co‑investment structures. Emphasis is on sector‑agnostic underwriting informed by rigorous operational due diligence, alignment-focused co-investments, and bespoke fund structuring to preserve upside while controlling downside. Strategy favors partnership with founders and sponsors, active portfolio advisory to accelerate scaling, and a multi-year horizon with disciplined risk controls and capital‑efficient value creation.
A boutique private‑markets advisor seeks to deploy patient, concentrated private‑markets capital into growth-stage and lower‑middle‑market companies via direct equity, credit and co‑investment structures. Emphasis is on sector‑agnostic underwriting informed by rigorous operational due diligence, alignment-focused co-investments, and bespoke fund structuring to preserve upside while controlling downside. Strategy favors partnership with founders and sponsors, active portfolio advisory to accelerate scaling, and a multi-year horizon with disciplined risk controls and capital‑efficient value creation.
| Trades 1342 | Longs Won 846/1342 63% | Profit Factor 6.31 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $346,622.54 |
| Average Win $88,330.96 | Best Trade (Aug 14) $7.5M | Sharpe Ratio -50.5 |
| Average Loss -$23,861.36 | Worst Trade (Mar 30) -$668,915 | Z-Score 2.18 (97.05%) |
| Commissions $0 | Avg. Trade Length 1y 1w 2d | Expectancy $46,864.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 15,873 | 14,286 | 12,698 | 11,111 | 9,524 | 7,937 | 6,349 | 4,762 | 3,175 | 1,587 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,121 | $495,684.78 | $655,198.11 | - | $159,513.33 | 32.18% | -7.354% |
ACWI iShares MSCI ACWI ETF | 5,085 | $719,477 | $795,446.5 | - | $75,969.5 | 10.56% | +0.495% |
ADMA Adma Biologics Inc. | 28,940 | $561,920.05 | $244,832.4 | - | -$317,087.65 | -56.43% | -2.422% |
AEM Agnico Eagle Mines Limited | 6 | $931 | $871.62 | - | -$59.38 | -6.38% | -3.635% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,372 | $231,344.73 | $230,961.64 | - | -$383.09 | -0.17% | -0.256% |
AGQ ProShares Ultra Silver | 12 | $537.86 | $767.16 | - | $229.3 | 42.63% | -4.425% |
AGX Argan Inc. | 713 | $201,978.46 | $406,716.58 | - | $204,738.12 | 101.37% | -1.628% |
ALL Allstate Corporation | 11 | $2,361 | $2,904.88 | - | $543.88 | 23.04% | -0.49% |
AMGN Amgen Inc. | 3 | $1,086 | $1,155.48 | - | $69.48 | 6.4% | -0.64% |
AMSC American Superconductor Corporation | 7,625 | $316,514 | $223,946.25 | - | -$92,567.75 | -29.25% | -0.272% |
AMT American Tower Corporation | 259 | $50,344 | $44,900.24 | - | -$5,443.76 | -10.81% | -0.631% |
AMZN Amazon.com Inc | 965 | $188,266.85 | $262,074.69 | - | $73,807.84 | 39.2% | +15.321% |
AMZY YieldMax AMZN Option Income Strategy ETF | 1,000 | $10,680 | $11,510 | - | $830 | 7.77% | +12.512% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 66 | $1,930 | $1,908.72 | - | -$21.28 | -1.1% | -0.035% |
ANGX Angel Studios, Inc. | 262 | $1,224 | $1,063.72 | - | -$160.28 | -13.09% | -0.733% |
ANIP Ani Pharmaceuticals Inc. | 6,200 | $397,441.43 | $491,288 | - | $93,846.57 | 23.61% | -1.48% |
ARKK ARK Innovation ETF Fund | 216 | $10,266.65 | $15,387.84 | - | $5,121.19 | 49.88% | -2.277% |
AVDE Avantis International Equity ETF | 862 | $68,343.59 | $78,623.02 | - | $10,279.43 | 15.04% | -0.458% |
AVDV Avantis International Small Cap Value ETF | 68,691 | $4.98M | $7.19M | - | $2.2M | 44.25% | -0.476% |
AVEM Avantis Emerging Markets Equity ETF | 88,015 | $6M | $7.88M | - | $1.87M | 31.2% | +0.101% |